Hays Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,999
Closed -$276K 32
2018
Q3
$276K Buy
1,999
+165
+9% +$21.9K 0.18% 64
2018
Q2
$223K Sell
1,834
-127
-6% -$15.8K 0.12% 65
2018
Q1
$251K Sell
1,961
-872
-31% -$118K 0.12% 69
2017
Q4
$396K Buy
2,833
+505
+22% +$70.3K 0.14% 64
2017
Q3
$303K Buy
2,328
+145
+7% +$19.2K 0.09% 61
2017
Q2
$289K Buy
2,183
+112
+5% +$14.3K 0.07% 60
2017
Q1
$258K Buy
2,071
+203
+11% +$24.3K 0.06% 62
2016
Q4
$215K Buy
+1,868
New +$216K 0.05% 65

Other funds holding JNJ

Hays Advisory's JNJ Position: Q4 2018 in Review

Hays Advisory sold out of Johnson & Johnson (JNJ) in Q4 2018, closing a stake of 1,999 shares — an estimated $276K sold.

Hays Advisory first reported a position in JNJ in Q4 2016 and held it in 8 quarters. The position peaked at $396K in Q4 2017. 2,765 funds tracked by Wall St. Rank hold JNJ as of Q4 2018.

  • Hays Advisory reported no remaining Johnson & Johnson position as of Q4 2018 after selling out during the quarter.
  • Hays Advisory sold 1,999 Johnson & Johnson shares in Q4 2018, an estimated $276K.
  • Hays Advisory first reported a position in Johnson & Johnson in Q4 2016 and held it in 8 quarters.
  • Hays Advisory's Johnson & Johnson position peaked at $396K in Q4 2017.
  • 2,765 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2018.

Based on Hays Advisory's 13F filing for Q4 2018.